Impact of Safinamide on Patient-Reported Outcomes in Parkinson’s Disease

Impact of Safinamide on Patient-Reported Outcomes in Parkinson’s Disease

Christian Espinoza-Vinces,1 Rafael Villino-Rodríguez,1 Ainhoa Atorrasagasti-Villar,1 Gloria Martí-Andrés,2 María-Rosario Luquin1 1Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain; 2Department of Neurology, Hospital Universitario de Navarra, Pamplona, SpainCorrespondence: Marí...

Full description

Bibliographic Details
Main Authors: Espinoza-Vinces C, Villino-Rodríguez R, Atorrasagasti-Villar A, Martí-Andrés G, Luquin MR
Format: Article
Language:English
Published: Dove Medical Press 2023-10-01
Series:Patient Related Outcome Measures
Subjects:
safinamide
parkinson’s disease
non-motor symptoms
monoamine oxidase inhibitors.
Online Access:https://www.dovepress.com/impact-of-safinamide-on-patient-reported-outcomes-in-parkinsons-diseas-peer-reviewed-fulltext-article-PROM

Internet

https://www.dovepress.com/impact-of-safinamide-on-patient-reported-outcomes-in-parkinsons-diseas-peer-reviewed-fulltext-article-PROM

Similar Items